Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q2 2021
Holdings as of Jun 30, 2021, filed Aug 16, 2021. Long positions only; changes compare share counts with Q1 2021.
- Positions
- 95
- +10 vs. Q1 2021
- Portfolio value
- $2.83B
- −$114.3M (−3.9%) vs. Q1 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $323.1M | 11.4% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 764,188 | $262.3M | 9.3% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 2,075,905 | $171.1M | 6.0% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 4,345,016 | $111.5M | 3.9% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 3,484,264 | $110.6M | 3.9% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 2,268,236 | $77.5M | 2.7% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $64.9M | 2.3% | 00.0% | Unchanged | History |
| SGENSeagen Inc. | COM | 400,000 | $63.2M | 2.2% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $62.1M | 2.2% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 2,084,883 | $57.3M | 2.0% | 00.0% | Unchanged | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 1,675,377 | $51.8M | 1.8% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 170,926 | $51.5M | 1.8% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,294,132 | $47.4M | 1.7% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $46.2M | 1.6% | 00.0% | Unchanged | History |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 2,400,000 | $43.1M | 1.5% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $41.6M | 1.5% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,534,598 | $41.2M | 1.5% | 00.0% | Unchanged | History |
| CNTBConnect Biopharma Holdings Ltd | ADS | 2,081,323 | $40.6M | 1.4% | 00.0% | Unchanged | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,341,009 | $40.4M | 1.4% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $40.0M | 1.4% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,287,782 | $39.3M | 1.4% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $33.7M | 1.2% | 00.0% | Unchanged | History |
| BMEABiomea Fusion, Inc. | COM | 2,088,405 | $32.6M | 1.2% | +2,088,405 | New | History |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $32.5M | 1.1% | 00.0% | Unchanged | History |
| ALGSAligos Therapeutics, Inc. | COM | 1,526,048 | $31.1M | 1.1% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $29.1M | 1.0% | 00.0% | Unchanged | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $27.7M | 1.0% | 00.0% | Unchanged | – |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $27.7M | 1.0% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $27.1M | 1.0% | +1,189,943 | New | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 6,000,000 | $26.3M | 0.9% | 00.0% | Unchanged | History |
| Therapeutics Acquisition Cor88339T103 | COM CL A | 2,500,000 | $25.7M | 0.9% | +1,000,000+66.7% | Added | – |
| PASGPassage BIO, Inc. | COM | 1,928,315 | $25.5M | 0.9% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 1,065,939 | $24.8M | 0.9% | 00.0% | Unchanged | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $24.6M | 0.9% | 00.0% | Unchanged | History |
| KDMNKadmon Holdings, Inc. | COM | 6,205,882 | $24.0M | 0.8% | 00.0% | Unchanged | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $22.4M | 0.8% | 00.0% | Unchanged | History |
| GHRSGH Research PLC | ORDINARY SHARES | 1,013,399 | $22.0M | 0.8% | +1,013,399 | New | History |
| AGENAgenus Inc | COM NEW | 4,000,000 | $22.0M | 0.8% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 1,050,289 | $21.9M | 0.8% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 250,000 | $20.9M | 0.7% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 2,562,358 | $20.8M | 0.7% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 831,495 | $20.6M | 0.7% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 904,227 | $20.1M | 0.7% | +904,227 | New | History |
| MREOMereo BioPharma Group plc | SPON ADS | 6,226,673 | $19.7M | 0.7% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 687,000 | $19.6M | 0.7% | 00.0% | Unchanged | History |
| ODTOdonate Therapeutics, Inc. | COM | 5,607,086 | $19.6M | 0.7% | 00.0% | Unchanged | History |
| CDAKCodiak BioSciences, Inc. | COM | 1,030,065 | $19.1M | 0.7% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $18.8M | 0.7% | 00.0% | Unchanged | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 714,500 | $18.3M | 0.6% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 1,175,000 | $18.3M | 0.6% | +1,175,000 | New | – |
| ELEVElevation Acquisition Group Inc. | COM | 1,341,530 | $18.2M | 0.6% | +1,341,530 | New | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 4,000,000 | $17.4M | 0.6% | 00.0% | Unchanged | History |
| TLISTalis Biomedical Corp | COM | 1,550,998 | $17.1M | 0.6% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 857,000 | $16.0M | 0.6% | +857,000 | New | History |
| SLDBSolid Biosciences Inc. | COM | 4,234,574 | $15.5M | 0.5% | 00.0% | Unchanged | History |
| FSTXF-star Therapeutics, Inc. | COM | 1,751,428 | $15.0M | 0.5% | +1,751,428 | New | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,536,016 | $15.0M | 0.5% | −1920.0% | Reduced | – |
| MISTMilestone Pharmaceuticals Inc. | COM | 2,572,194 | $14.1M | 0.5% | 00.0% | Unchanged | History |
| NGNENeurogene Inc. | COM | 1,501,058 | $13.9M | 0.5% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 1,603,361 | $13.8M | 0.5% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $13.7M | 0.5% | 00.0% | Unchanged | History |
| PSTXPoseida Therapeutics, Inc. | COM | 1,251,055 | $12.5M | 0.4% | 00.0% | Unchanged | History |
| ESPREsperion Therapeutics, Inc. | COM | 500,000 | $10.6M | 0.4% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 1,000,000 | $10.6M | 0.4% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $9.86M | 0.3% | +500,000 | New | History |
| IMMPIMMUTEP Ltd | SPONSORED ADS | 2,500,000 | $9.68M | 0.3% | +500,000+25.0% | Added | History |
| Bellus Health Inc New07987C204 | COM NEW | 2,975,000 | $9.25M | 0.3% | 00.0% | Unchanged | – |
| MTNBMatinas BioPharma Holdings, Inc. | COM | 11,478,634 | $8.89M | 0.3% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 1,300,000 | $8.41M | 0.3% | 00.0% | Unchanged | History |
| LITSLite Strategy, Inc. | COM NEW | 2,913,091 | $8.30M | 0.3% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 250,000 | $7.70M | 0.3% | 00.0% | Unchanged | History |
| NAUTNautilus Biotechnology, Inc. | COM | 750,000 | $7.58M | 0.3% | +750,000 | New | History |
| VINCVincerx Pharma, Inc. | COM NEW | 450,000 | $5.85M | 0.2% | +450,000 | New | History |
| ASMBAssembly Biosciences, Inc. | COM | 1,500,000 | $5.82M | 0.2% | 00.0% | Unchanged | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 317,000 | $5.48M | 0.2% | 00.0% | Unchanged | History |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $5.26M | 0.2% | 00.0% | Unchanged | – |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $5.07M | 0.2% | 00.0% | Unchanged | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $5.01M | 0.2% | +500,000 | New | – |
| JYACJiya Acquisition Corp. | COM CL A | 500,000 | $4.97M | 0.2% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 400,000 | $4.13M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $4.08M | 0.1% | 00.0% | Unchanged | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 290,577 | $4.05M | 0.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 550,000 | $3.83M | 0.1% | 00.0% | Unchanged | History |
| LJPCLa Jolla Pharmaceutical Co | COM PAR $.0001 2 | 890,700 | $3.81M | 0.1% | 00.0% | Unchanged | History |
| Catabasis Pharmaceuticals IN14875P206 | COM NEW | 1,775,000 | $3.75M | 0.1% | +1,775,000 | New | – |
| ORICOric Pharmaceuticals, Inc. | COM | 200,000 | $3.54M | 0.1% | 00.0% | Unchanged | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 1,134,453 | $2.65M | 0.1% | 00.0% | Unchanged | History |
| Consonance HFW Acquisition CG2445M129 | UNIT 99/99/9999 | 200,000 | $2.04M | 0.1% | 00.0% | Unchanged | – |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $2.04M | 0.1% | 00.0% | Unchanged | History |
| SNCEScience 37 Holdings, Inc. | COM | 200,000 | $2.00M | 0.1% | 00.0% | Unchanged | History |
| Omega Alpha SpacG6749V107 | CL A | 200,000 | $1.99M | 0.1% | 00.0% | Unchanged | – |
| CLRBCellectar Biosciences, Inc. | COM PAR | 920,000 | $1.09M | <0.1% | 00.0% | Unchanged | History |
| BOLTBolt Biotherapeutics, Inc. | COM | 50,000 | $773.0K | <0.1% | 00.0% | Unchanged | History |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $693.0K | <0.1% | 00.0% | Unchanged | – |
| ZGNXZogenix, Inc. | COM NEW | 27,300 | $472.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2021 (3)
Positions held at the end of Q1 2021 that are gone from this filing.
| Security | Class | Shares in Q1 2021 | Value in Q1 2021 | % of portfolio in Q1 2021 | History |
|---|---|---|---|---|---|
| Direxion Shs ETF Tr25460G716 | DAILY S&P BIOTEC | 1,250,000 | $27.2M | 0.9% | – |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 750,000 | $10.3M | 0.4% | History |
| Vincerx Pharma, Inc.92731L205 | UNIT 12/24/2025 | 300,000 | $8.10M | 0.3% | – |